Prescription Drugs Market Research Reports & Industry Analysis
The prescription drugs industry is a key cornerstone of healthcare, delivering vital medications that improve and save lives. As this industry continues to evolve, understanding its nuances can be an ongoing challenge. MarketResearch.com provides hundreds of authoritative prescription drugs market research reports to help stakeholders understand the shifting market landscape and devise effective business strategies.
The Latest Prescription Drugs Market Analysis
- We provide data-packed reports on a wide range of product types, therapeutic areas, regions, and companies.
- Our research includes in-depth analyses of prescription drug market size, growth forecasts, and drivers and challenges.
- In addition, we cover the rise of personalized medicine and gene therapies, as well as regulatory issues and pricing models.
Your Dedicated Research Partner
As the prescription drugs industry shifts and changes, MarketResearch.com equips you with the tools to thrive. Trusted for decades as a reliable research partner, our clients include top pharmaceutical companies, investment banks, and universities. Whether you are exploring new markets or seeking to futureproof your business, our prescription drugs industry research reports offer a wealth of knowledge to inform your strategy. Get started by exploring our vast selection of reports on the prescription drugs industry today.
Prescription Drugs Industry Research & Market Reports
-
Global Narcotics Scanner Market by Product Type (Desktop, Handheld), Technology (Ion Mobility Spectrometry Technology, Raman Mass Spectrometry, Infrared Spectroscopy), End-user Industry (Aviation/Customs and Borders, Defense and Military, Law Enforcement), Regional Forecasts 2021-2027
... Market is valued approximately at USD 6.89 billion in 2020 and is anticipated to grow with a healthy growth rate of more than 6.3% over the forecast period 2021-2027. Narcotics scanners are used by law ... Read More
-
Hospital-Acquired Infection Control Market: Current Analysis and Forecast (2021-2027)
... the infections that occur in hospitals due to contaminated equipment, furniture, washrooms, or others. Diseases like sepsis, tuberculosis, and influenza are commonly spread from hospitals. With the rapid advancement in sterilization technology and rising awareness ... Read More
-
Global Antimicrobial Resistance Market Report, by Drug Class, By Disease Type, By Pathogen Type, By End-user and Region, Trends & Growth Opportunity and Forecast – 2030
... 16.4 Bn by 2030 According to SPER Market Research, the global antimicrobial resistance market (AMR) was valued at USD 10.2 Bn in 2021 and estimated to reach USD 16.4 Bn by 2030 with a CAGR ... Read More
-
Allergy Care Market Analysis by Allergy Type (Eye Allergy, Skin Allergy, Food Allergy), by Product (Nasal Spray, Antihistamine Medication, Eye Drops), by Form (Tablet/Gels/Pills, Sprays, Liquids), by Sales Channel, by Region - Global Forecast 2022-2032
... Allergy Care Market- Scope of Report A recent study by Fact.MR on the allergy care market offers a 10-year forecast for 2022 to 2032. The study analyzes crucial trends that are currently determining the growth ... Read More
-
Herpes Zoster Treatment Market by Treatment Type (Antiviral Medications, Anti Inflammatory Medications, and Others) Route Administration (Oral, and Topical) and Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers): Global Opportunity Analysis and Industry Forecast, 2021-2030
... and Industry Forecast, 2021-2030 The global herpes zoster treatment market was valued at $217.09 million in 2020, and is projected to reach $303.42 million by 2030, registering a CAGR of 3.4% from 2021 to 2030. ... Read More
-
4-1BB receptor Agonist - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
5-Alpha Reductase Inhibitor - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
5-HT7 Antagonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
PDE 10 inhibitor - Pipeline Insight, 2022
... of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the ... Read More
-
Copaxone - API Insight, 2022
... and other development activities. It further provides Copaxone's patents information (US & EU). It also features the historical and forecasted sales of Copaxone 2024. The report also highlights Copaxone's market competition and emerging therapies which ... Read More
-
Invokana - API Insight, 2022
... and other development activities. It further provides Invokana's patents information (US & EU). It also features the historical and forecasted sales of Invokana 2024. The report also highlights Invokana's market competition and emerging therapies which ... Read More
-
Kivexa - API Insight, 2022
... and other development activities. It further provides Kivexa's patents information (US & EU). It also features the historical and forecasted sales of Kivexa 2024. The report also highlights Kivexa's market competition and emerging therapies which ... Read More
-
Lunesta - API Insight, 2022
... and other development activities. It further provides Lunesta's patents information (US & EU). It also features the historical and forecasted sales of Lunesta 2024. The report also highlights Lunesta's market competition and emerging therapies which ... Read More
-
Prezista - API Insight, 2022
... and other development activities. It further provides Prezista's patents information (US & EU). It also features the historical and forecasted sales of Prezista 2024. The report also highlights Prezista's market competition and emerging therapies which ... Read More
-
Pristiq - API Insight, 2022
... and other development activities. It further provides Pristiq's patents information (US & EU). It also features the historical and forecasted sales of Pristiq 2024. The report also highlights Pristiq's market competition and emerging therapies which ... Read More
-
Sprycel - API Insight, 2022
... and other development activities. It further provides Sprycel's patents information (US & EU). It also features the historical and forecasted sales of Sprycel 2024. The report also highlights Sprycel's market competition and emerging therapies which ... Read More
-
Substance (Drug) Abuse - Epidemiology Forecast to 2032
... Spain, Italy, France, and the United Kingdom), and Japan. Geographies Covered • The United States • EU5 (Germany, France, Italy, Spain, and the United Kingdom) • Japan Study Period: 2019-2032 Substance (Drug) Abuse Understanding The ... Read More
-
5-HT1 Agonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
5-HT2C Antagonist - Pipeline Insight, 2022
... pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered across the following Developmental ... Read More
-
Adenosine A1 Receptor Agonist - Pipeline Insight, 2022
... detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type. Pipeline Products covered ... Read More
-
Advair Diskus - API Insight, 2022
... partnerships, clinical trials and other development activities. It further provides Advair Diskus's patents information (US & EU). It also features the historical and forecasted sales of Advair Diskus 2024. The report also highlights Advair Diskus's ... Read More
-
Aristada - API Insight, 2022
... and other development activities. It further provides Aristada's patents information (US & EU). It also features the historical and forecasted sales of Aristada 2024. The report also highlights Aristada's market competition and emerging therapies which ... Read More
-
Combivir - API Insight, 2022
... and other development activities. It further provides Combivir's patents information (US & EU). It also features the historical and forecasted sales of Combivir 2024. The report also highlights Combivir's market competition and emerging therapies which ... Read More
-
Duavee - API Insight, 2022
... and other development activities. It further provides Duavee's patents information (US & EU). It also features the historical and forecasted sales of Duavee 2024. The report also highlights Duavee's market competition and emerging therapies which ... Read More
-
Efient - API Insight, 2022
... and other development activities. It further provides Efient's patents information (US & EU). It also features the historical and forecasted sales of Efient 2024. The report also highlights Efient's market competition and emerging therapies which ... Read More
Research Assistance
